chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This was my first shot and I am a little concerned with getting the next one. Long family history of hear disease. My symptoms started that night after the shot: Rapid heart beat - lasted over an hour - continued having daily episodes (this is my biggest concern, seeing a cardiologist next Friday.) Face felt very hot and head was sweaty multiple times each day (starting to subside, I think.) Joint pain was very severe - pain was twice the normal amount of daily pain, again, having daily episodes but seems to be lessening. Exhaustion - still have issues with this Loss of appetite.
Rash on right arm very itchy; Very itchy and irritating; Pain in left eye/eye ball pain; Feels like pink eye; Left eye more pain to touch than swelling.; weird sensation if drinking alcohol, felt really strange and can not drink; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 24Mar2021 at 15:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included endometriosis. The patient did not have any allergies to food, medicine and other product. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the right arm on 03Mar2021 at 15:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021, two weeks after the vaccination, the patient experienced rash on right arm, very itchy and irritating and on the third day it was getting worse. The patient also experienced pain in left eye which felt like pink eye, but more pain to touch than swelling, the pain moved up into the eye ball. The patient also had a very weird sensation when drinking alcohol, he had one sip and felt really strange and could not drink. Therapeutic measures were not taken as a result of the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events rash on right arm which was very itchy and irritating, pain in left eye which felt like pink eye with more pain to touch than swelling, weird sensation when drinking alcohol which felt really strange and can not drink was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Fluzone High Dose was inadvertently administered to patient under the age of 65.  Previous provider had administered High Dose and 1 extra (unused) vial remained at administration site instead of being returned to storage.  Assistant set up area, and provider assumed correct vaccine was provided.  Provider did not check vaccine name prior to administration and did not realize mistake until documenting vaccine administration.   Patient has been informed.
severe impotence; This is a spontaneous report from a contactable consumer (patient). A 56-year-old male patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, LOT/Batch number and expiration date unknown) via an unspecified route of administration at arm left on 29Mar2021 09:00 AM at age of 56-year-old for COVID-19 immunization. Medical history and concomitant medications were not reported. There was no known allergies. Patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient wasn't diagnosed with COVID-19. Since the vaccination, patient wasn't tested for COVID-19. After taking the first shot two weeks later (as reported), patient started experiencing severe impotence and he was still going through this he had never been this way before. Onset date of the event was reported as 29Mar2021. Event was reported as non-serious. No treatment was received for the event. Outcome of the event was not recovered.  Information about lot/batch number was available. Further information was expected.
After injection with influenza vaccine, noticed erythema around site of injection. Shortly thereafter, noticed hive across upper back. Resolved on it's own.
I had fatigue and headaches for four days after the vaccine. I had a headache that would not go away. I had brain fog and tiredness and I was out of breath. After four weeks it had gotten worse but I still took the second vaccine. I went to the ER on 03/24/2021 and then I got the second dose two days later.  I had to go to the ER and 03/30/2021 because I was having more trouble breathing.  I have been seeing a Pulmonologist and Infectious Disease doctor. I was diagnosed with  Scedlsporium and Fungal Pneumonia. I also have severe Lymphedema. I had a lot of swelling all over my doctor. I have also been taking Insulin since the vaccine. I had had Rheumatoid Arthritis but it was well controlled with Advil. The Rheumatoid Arthritis is flared since the vaccine and I have been seeing a specialist for that. Twelve weeks out from the vaccine and it is very difficult to work and I still have all of the problems and they are getting worse. My providers have been trying multiple medications and nothing has helped and some of them have been detrimental to my health.
Rash on leg and left hand, top of hands/Rash; itching on top of the left hand started today; weakness; Diarrhea; feeling tired; Light-headed; Stomach pain; felt sick to stomach; felt sick; body aching; his arm is sore/soreness in arm; Says his asthma acted up; Nausea; This is a spontaneous report from a contactable consumer or other non hcp. A 19-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution of injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Right on 07Aug2021 (at the age of 19-years-old) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing, attention deficit hyperactivity disorder from an unknown date and unknown if ongoing, cardiac disorder from an unknown date and unknown if ongoing narrowing of the main vein in his heart, instead it was going straight. They were going to do open heart surgery, but it fixed itself, hypersensitivity from an unknown date and unknown if ongoing he has allergies. The patient's concomitant medications were not reported. On Aug2021, the patient experienced, nausea and says his asthma acted up. On 08Aug2021, the patient experienced his arm is sore/soreness in arm, diarrhoea, feeling tired, light-headed, stomach pain, felt sick to stomach; felt sick, body aching. On 09Aug2021, the patient experienced weakness. On 10Aug2021, the patient experienced top of hands/rash, itching on top of the left hand started today a rash on leg and left hand, top of hands/rash. Reporter reports her son received the first dose of the Pfizer Covid 19 vaccine on 07Aug2021 and 24 hours later he began to experience side effects of soreness in the arm, diarrhea, and rash, feeling tired and lightheaded, stomach pain, and now today he began to have a rash on the leg and left hand. He has ADHD, has asthma and a heart condition. Had called to verify that these are side effect. Reporter clarifies patient had ADHD, asthma, and heart condition at birth before administration of product. Later provides patient was born with a heart condition, with narrowing of the main vein in his heart, instead it was going straight. They were going to do open heart surgery, but it fixed itself. Therapeutic measures were taken as a result of, itching on top of the left hand started today (pruritus), says his asthma acted up (asthma). The outcome of the event arm was sore/soreness in arm, weakness, diarrhoea, feeling tired, felt sick to stomach; felt sick, body aching, says his asthma acted up was unknown and the remaining all events was not recovered.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
really severe cold symptoms; fell like I might pass out; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (really severe cold symptoms) and PRESYNCOPE (fell like I might pass out) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003BNA) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced NASOPHARYNGITIS (really severe cold symptoms) and PRESYNCOPE (fell like I might pass out). At the time of the report, NASOPHARYNGITIS (really severe cold symptoms) and PRESYNCOPE (fell like I might pass out) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On the morning of 07-Apr-2021 the patient took Advil and a typical severe cold and cough medication. He's drinking a lot of water.
The needle came off the syringe. The medic felt that .50-.75% of the dose was administered.  Department of Public Health notified and dose will not be repeated.
Initial unsolicited report received from a nurse on 20-Oct-2017. This case is linked to case 2017SA207218 and 2017SA207221 (same reporter, same vaccine, different patient). This case involves a female patient (age at time of the reaction was not reported) who was vaccinated with a 0.5 ml single dose of FLUZONE QIV (batch number, expiry date, dose in series and site of administration were not reported) via intramuscular route on 04-Oct-2017 at flu clinic. Patient's medical history and concomitant medications were not reported. On an unknown date, following the vaccination, the patients developed hives, shortness of breath and multiple allergies. Laboratory tests were not reported. As corrective treatment, the patient required EPINEPHRINE (EPI PEN). On an unknown date, the patient recovered from all the events. List of documents held by sender: none.
This spontaneous report as received from a pharmacist refers to a 67 year old female patient. On 23-MAR-2015, the patient was vaccinated with a dose of ZOSTAVAX lot # K024031, expiration date; February 2016 (dose and route of administration were not reported). On 23-MAR-2015, the patient experienced red spot which looked "like the size of a nickel" at the injection site and could possibly be a rash. The patient sought medical attention: spoke to the pharmacist. No treatment was given for the adverse event. The outcome of the event was reported as not recovered. Relatedness between the event and vaccination with ZOSTAVAX was not reported. Additional information has been requested.
Not able to walk; A spontaneous report was received from a [consumer/physician/nurse/pharmacist/healthcare facility staff member/regulatory authority report]  concerning a [age/gender] patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and became unable to walk/gait disturbance.   The patient's medical history was not provided.  Products known to have been used by the patient, within two weeks prior to the event, included unspecified psychiatric medications.   On 19 Jan 2021, approximately two days prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (batch number not provided) intramuscularly for prophylaxis of COVID-19 infection.   The patient lost the ability to walk on 21 Jan 2021 and was hospitalized.  He was entered into a rehabilitation facility where he was to start treatment with a physical therapist to walk again.  Action taken with mRNA-1273 in response to the events was not provided.   The outcome of the events fatigue, body aches, loss of taste, chills, and temperature of 99 degrees were not reported.  Reporter causality for the events was not provided.; Reporter's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested. Company assessed the event to be unlikely related to company product.
Fever up to 104, nausea, vomiting, body aches, headache
Three to four hours the vaccine was given the patient reported having trouble breathing and shaking. The patient works at the grocery store and was at work at the time. She sat down and 911 was called. They checked her vitals and determined she was ok and sent her home with her father. No medications were administered.
Upper left arm became red, warm, and slightly swollen which was noticed the morning after the vaccine was administered. It encompassed most of the upper arm about 75% around. By the next morning 100% of upper arm was involved. The patient applied an ice pack, and had also taken 2 doses of acetaminophen during the day after vaccine was administered. About 96 hours after the vaccination, complete resolution of all signs and symptoms had resolved.
On February 2, 2021 at approx 12pm I started to get a headache. Later that evening a stiff neck.  This morning I woke at 4:30am with the right arm swollen, red and painful at the injections site.  The pain radiates to my right shoulder and under my arm.  Redness is approx 2.5 in diameter.
Initial unsolicited report received from a nurse on 03-Nov-2016. This case involves a 55-year-old female patient, who was vaccinated FLUZONE via intramuscular route (batch number: UI657AB, expiry date: 30-Jun-2017) (dose and dose in series not reported) in left deltoid on 04-Oct-2016. Patient's illness at time of vaccination and pre-existing physician diagnosed allergies were reported as unknown. Concomitant medications were not reported. On 22-Oct-2016, 17-day following the vaccination, the patient had shingles symptoms. On 28-Oct-2016, 23-day after vaccination patient had visible outbreak. It was also reported that a physician diagnosed the event as shingles. Patient required ER/doctor visit. Lab test and concomitant medication was not reported. Outcome of the events were reported as not recovered. Upon internal review the case was considered as serious because of important medical event: shingles. Documents held by sender: none. Sender's Comments: This case concerns 55 years old female who received INFLUENZA QUADRIVAL A-B VACCINE and experienced Shingles. Time to onset 18 days is compatible with the role of vaccine. Shingles is due to a reactivation of varicella zoster virus (VZV) within a patient's body. Details regarding relevant medical history, any previous history of Chickenpox and information on infections occurring prior to vaccination are needed for complete assessment of the case. Based on the available information role of the vaccine can be excluded.
From July 2021 on I have had brain fog, unable to concentrate. In March 31, 2022 I had post menopausal bleeding. I underwent a hysteroscopy and a dilation & curettage and found stage 2 grade 2 endometrial/uterine cancer. I am having a full hysterectomy June 16, 2022.
COVID-19 Vaccine EUA Ten days after the injection of Covid 19 injection my arm swelled up, and became very red and itchy at the site of the injection.  It just came up out of nowhere it seems as I had no reaction at all to the vaccine during the prior 10 days since the vaccination. This continued for two days.  The first day after it happened I felt tired and weak in the morning.  I got into work here at the house and the weakness went away.  I treated the itchy situation with Clobetasol Propionate Cream which I had here and was prescribed by my dermatologist for poison ivy.  That took away the itchy situation that was very annoying.  Two days into it the swelling began to go down.  Today is the 4th day since the problem occurred and there is no swelling and only a slight redness.  I am assuming that I can take injection #2 on February 9 as scheduled.
The gray cap Pfizer bivalent booster dose was administered to an 11 year old patient instead of the orange cap formulation.
gray dots that have been noted on patient's legs on right thigh  after receiving Pediarix, Hiberix and/or Prevnar.; This case was reported by a pharmacist and described the occurrence of skin discoloration in a 4-month-old patient who received DTPa-HBV-IPV (Pediarix) (batch number N7HL3, expiry date unknown) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis, Hib (Hiberix) (batch number BD27G, expiry date unknown) for prophylaxis and PNEUMOCOCCAL VACCINE (PREVENAR) for prophylaxis.   Previously administered products included Pediarix (On 8th Jun 2022 1st dose received of Pediarix and Hiberix For tolerance to the 1st dose refer case US2022AMR171034) and Hiberix.   On 11th August 2022, the patient received the 2nd dose of Pediarix, Pediarix Pre-Filled Syringe Device and the 2nd dose of Hiberix. On an unknown date, the patient received PREVENAR. On an unknown date, less than 3 months after receiving Pediarix, Pediarix Pre-Filled Syringe Device and Hiberix, the patient experienced skin discoloration. On an unknown date, the outcome of the skin discoloration was unknown.   It was unknown if the reporter considered the skin discoloration to be related to Pediarix, Pediarix Pre-Filled Syringe Device and Hiberix.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Linked case(s) involving the same patient:  US2022AMR171034, US2022AMR171042   Additional Information: GSK Receipt Date: 16-NOV-2022 Reporter's Comments:  The patient experienced the gray dots on right thigh that have been noted on patient's legs after receiving Pediarix and Hiberix. The reporter consented to follow up. Additional supportive information: For tolerance to the 3rd dose refer case US2022AMR171042. This was 1 of 19 linked cases, reported by same reporter It was unknown if the reporter considered the skin discoloration to be related to Prevenar.; Sender's Comments:  US-GSK-US2022AMR171025:Same reporter US-GSK-US2022AMR171007:Same reporter US-GSK-US2022AMR171047:Same reporter US-GSK-US2022AMR149551:Same reporter US-GSK-US2022AMR148962:Same reporter US-GSK-US2022AMR171025:Same reporter US-GSK-US2022AMR171007:Same reporter US-GSK-US2022AMR171034:Same reporter US-GSK-US2022AMR171028:Same reporter US-GSK-US2022AMR171042:Same reporter US-GSK-US2022AMR149560:Same reporter US-GSK-US2022AMR148961:Same reporter US-GSK-US2022AMR149561:Same reporter US-GSK-US2022AMR148919:Same reporter US-GSK-US2022AMR171044:Same reporter US-GSK-US2022AMR171048:Same reporter US-GSK-US2022AMR171050:Same reporter US-GSK-US2022AMR171052:Same reporter US-GSK-US2022AMR171056:Same reporter US-GSK-US2022AMR171062:Same reporter
Extremely swollen, red and hard injection site. It started the day after my booster (Friday). And it's still there, actually worse. It's about 5-in diameter. I had soreness with my initial vaccines but nothing like this. It's bearable, but very uncomfortable.
4-25-2021 - 01:30 - Extreme chills and body aches - no sleep that night 4-25-2021 - 08:00 - body and muscle aches making laying down uncomfortable 4-25-2021 - 010:00 - fever and chills returned 4-25-2021 - 13:00 - sinus headache and continued body aches with fatigue continued through the day 4-26-2021 - 04:45 - sore throat, shortness of breath, and cough - persisted throughout the day - body aches and sinus headache dissipated 4-27-2021 - 10:00 -  light headedness spells throughout the day along with foggy mind 4-27-2021 09:00 - continue sore throat and cough but much less severe - foggy mind continues 04-27-2021 - mild looking shingle/blister bumps on my hands and arms. should I be concerned? sore throat continues but is going away
Aggressive convulsions, in 5 minute spurts, with pauses between, for roughly 3 hours 11:00pm to 2:00am.
Reoccurring pain in left arm after PREVNAR vaccine administered 8/13/16 and continuing as of 2/3/17; patient has sought no medical attention against pharmacists advice to do so.
Bell's palsy - loss of ability to move right side of face beginning approximately 3 weeks after vaccine booster. Started course of treatment with steroids and antiviral medication.
Information has been received from a RN concerning a 7 month old pt who had not been vaccinated because of his age but came down with the chickenpox. The RN reported his older sibling who had been vaccinated with varicella virus vaccine live "broke out with a moderate case of chicken pox" two weeks later, reported as 26Apr03. Unspecified medical attention was sought. The reporter mentioned that two other siblings also "broke out with moderate cases of chickenpox" following vaccination with varicella virus vaccine live. Additional information has been requested.
At approximately 9pm the night of the vaccine 2nd dose, I developed a fever. As the night progressed, I also developed severe R arm pain, joint pain, muscle aches in my back, chills, a headache, and fatigue. The fever was as high as 103.1 and improved with tylenol, but lasted for 2 days. Since onset of the back pain, it has persisted and gradually worsened over the past 2 weeks since the injection. I contact my physician, received a prescription for a muscle relaxant, and a referral for physical therapy.
My first shot only made my arm sore.  The second shot my arm was sore, but the following day a red rash the size of my hand came up on my arm and lasted 5 days.  The injection site itched still a week later even after the redness went away.
Patient said as soon as he received immunization he couldn't move his arm. He went to ER and Md gave patient ibuprofen and range of motion improved.
On 5/8/08, the patient was seen for left lateral thigh with 10 1/2cm x9 1/2cm area that was red, indurated, slightly warm and painful. Possibly early cellulitis. Treatment included Clindamycin x7 days and Motrin for pain.
Felt lightheaded, had headache and nausea, 2 days later, chest pressure.  Lasted 7 days, ER visit (10/21/09) doctor visit (10/22/09) No treatment.
Morbiliform rash - onset 3 days after. Was seen  about a week after and rx-ed steroids and hydroxyzine. Sx persisted and was evaluated in my clinic.
I first got a swollen arm at site, and a slight rash, which went away then came back a week later slightly. then I developed what I thought were bug bites on my eyelids, itchy and red bumps. The next day I had a few more. The third day I woke with my eyes almost swollen shut and more itchy red bumps on my face, spread to my neck, now my chest and back. a few at a time
Fever of 101, lymph nodes on right side in arm pit swollen up it was the size of a ping pong ball, it was painful. Lymph nodes last for about 6 weeks.
Patient felt faint and flushed. She appeared to lose consciousness for a few seconds. We gave her alcohol to smell and elevated her legs. She felt better but continued to feel light-headed, with fuzzy vision and difficulty hearing. Fire rescue came and evaluated her and she was okay to leave with her partner.